These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34813879)

  • 61. Drug crystallization - implications for topical and transdermal delivery.
    Hadgraft J; Lane ME
    Expert Opin Drug Deliv; 2016 Jun; 13(6):817-30. PubMed ID: 26766744
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 3D printed microneedles for insulin skin delivery.
    Pere CPP; Economidou SN; Lall G; Ziraud C; Boateng JS; Alexander BD; Lamprou DA; Douroumis D
    Int J Pharm; 2018 Jun; 544(2):425-432. PubMed ID: 29555437
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
    Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
    Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bioresponsive transcutaneous patches.
    Yu J; Zhang Y; Kahkoska AR; Gu Z
    Curr Opin Biotechnol; 2017 Dec; 48():28-32. PubMed ID: 28292673
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Device-assisted transdermal drug delivery.
    Lee H; Song C; Baik S; Kim D; Hyeon T; Kim DH
    Adv Drug Deliv Rev; 2018 Mar; 127():35-45. PubMed ID: 28867296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent update on alginate based promising transdermal drug delivery systems.
    Manna S; Gupta P; Nandi G; Jana S
    J Biomater Sci Polym Ed; 2023 Dec; 34(16):2291-2318. PubMed ID: 37368494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
    Ham AS; Buckheit RW
    Ther Deliv; 2015 Feb; 6(2):217-29. PubMed ID: 25690088
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
    Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
    Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microneedles for transdermal drug delivery using clay-based composites.
    Sabbagh F; Kim BS
    Expert Opin Drug Deliv; 2022 Sep; 19(9):1099-1113. PubMed ID: 36036395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advances in the Novel Nanotechnology for Targeted Tumor Therapy by Transdermal Drug Delivery.
    Wang Y; Jiang G
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2708-2714. PubMed ID: 35319394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tissue Interlocking Dissolving Microneedles for Accurate and Efficient Transdermal Delivery of Biomolecules.
    Fakhraei Lahiji S; Kim Y; Kang G; Kim S; Lee S; Jung H
    Sci Rep; 2019 May; 9(1):7886. PubMed ID: 31133711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fast-drying multi-laminate bioadhesive films for transdermal and topical drug delivery.
    Donnelly RF; McCarron PA; Morrow DI; Woolfson AD
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1818-31. PubMed ID: 23167263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transdermal delivery: product and patent update.
    Gupta H; Babu RJ
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):184-205. PubMed ID: 24025130
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy.
    Qindeel M; Ullah MH; Fakhar-Ud-Din ; Ahmed N; Rehman AU
    J Control Release; 2020 Nov; 327():595-615. PubMed ID: 32920080
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multifunctional Smart Skin Adhesive Patches for Advanced Health Care.
    Hwang I; Kim HN; Seong M; Lee SH; Kang M; Yi H; Bae WG; Kwak MK; Jeong HE
    Adv Healthc Mater; 2018 Aug; 7(15):e1800275. PubMed ID: 29757494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.